FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案)

2019-11-22 美国食品和药品监督管理局

Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE

中文标题:

FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案)

英文标题:

Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE

发布日期:

2019-11-22

简要介绍:

Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE


相关资料下载:
[AttachmentFileName(sort=100, fileName=FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案))] GetToolGuiderByIdResponse(projectId=1, id=d7a4a1c001830a04, title=FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案), enTitle=Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE, guiderFrom=, authorId=null, author=, summary=Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE, cover=, journalId=null, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商,其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Fri Nov 22 21:32:23 CST 2019, originalUrl=, linkOutUrl=, content=Transdermal and Topical Delivery Systems - Product Development and Quality Considerations Guidance for Industry DRAFT GUIDANCE<div><br></div>, tagList=[], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10354, appHits=49, showAppHits=5, pcHits=2714, showPcHits=9568, likes=83, shares=2, comments=2, approvalStatus=1, publishedTime=Fri Nov 22 21:32:23 CST 2019, publishedTimeString=2019-11-22, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Fri Nov 22 21:32:23 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 02:14:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案))])
FDA指南《透皮和局部递药系统 – 产品研发和质量考量》(草案)
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=805978, encodeId=9e7b8059e805, content=我下载不了!谁下载了,好心人给发一份!zhaojiale66@126.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5408628, createdName=zhaojiale, createdTime=Mon Aug 03 21:45:48 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804360, encodeId=018b8043604c, content=能保存吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0185402615, createdName=hellen, createdTime=Fri Jul 24 18:56:33 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-08-03 zhaojiale

    我下载不了!谁下载了,好心人给发一份!zhaojiale66@126.com

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=805978, encodeId=9e7b8059e805, content=我下载不了!谁下载了,好心人给发一份!zhaojiale66@126.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5408628, createdName=zhaojiale, createdTime=Mon Aug 03 21:45:48 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804360, encodeId=018b8043604c, content=能保存吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0185402615, createdName=hellen, createdTime=Fri Jul 24 18:56:33 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-07-24 hellen

    能保存吗

    0